Doctors Who Prescribe Empagliflozin (Jardiance, Glyxambi, Synjardy, Trijardy) in Wisconsin
Also known as: Jardiance, Glyxambi, Synjardy, Trijardy
Find doctors, physicians, and healthcare providers who prescribe Empagliflozin in Wisconsin. This page lists the top prescribers of Empagliflozin based on Medicare Part D data, including the number of claims, patients served, and total drug costs.
What is Empagliflozin?
SYNJARDY SYNJARDY is a combination of empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor and metformin hydrochloride (HCl) immediate-release, a biguanide, indicated as an additional treatment to diet and exercise to improve glycemic control in adults and children aged 10 years and older with type 2 diabetes. It belongs to a class of drugs known as sodium-glucose cotransporter 2 inhibitor.
Total Claims in Wisconsin
141,680
1.9% of all Empagliflozin prescriptions nationwide
Data Source: Prescribing data aggregated from the official CMS.gov Medicare Part D Prescribers by Provider and Drug dataset, published by the Centers for Medicare & Medicaid Services. Data Current As Of: 2023 (most recent CMS release). Individual prescriber counts below 11 are suppressed by CMS for patient privacy.